V.F. Corporation (LON:0R30)

SpringWorks Therapeutics Statistics

Total Valuation

LON:0R30 has a market cap or net worth of GBP 3.43 billion. The enterprise value is 7.18 billion.

Market Cap	3.43B
Enterprise Value	7.18B

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	390.62M
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	387.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	14.79
PS Ratio	0.50
PB Ratio	3.65
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.20, with an EV/FCF ratio of 47.04.

EV / Earnings	-208.32
EV / Sales	1.02
EV / EBITDA	7.20
EV / EBIT	18.85
EV / FCF	47.04

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 4.39.

Current Ratio	1.27
Quick Ratio	0.53
Debt / Equity	4.39
Debt / EBITDA	4.24
Debt / FCF	27.13
Interest Coverage	2.95

Financial Efficiency

Return on equity (ROE) is 7.83% and return on invested capital (ROIC) is 4.14%.

Return on Equity (ROE)	7.83%
Return on Assets (ROA)	2.95%
Return on Invested Capital (ROIC)	4.14%
Return on Capital Employed (ROCE)	7.63%
Revenue Per Employee	320,584
Profits Per Employee	-1,595
Employee Count	27,000
Asset Turnover	0.88
Inventory Turnover	2.06

Taxes

In the past 12 months, LON:0R30 has paid 57.66 million in taxes.

Income Tax	57.66M
Effective Tax Rate	42.97%

Stock Price Statistics

The stock price has decreased by -33.94% in the last 52 weeks. The beta is 1.71, so LON:0R30's price volatility has been higher than the market average.

Beta (5Y)	1.71
52-Week Price Change	-33.94%
50-Day Moving Average	12.33
200-Day Moving Average	17.41
Relative Strength Index (RSI)	45.68
Average Volume (20 Days)	22,437

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.80

Income Statement

In the last 12 months, LON:0R30 had revenue of GBP 6.92 billion and -34.45 million in losses. Loss per share was -0.09.

Revenue	6.92B
Gross Profit	3.74B
Operating Income	373.38M
Pretax Income	134.19M
Net Income	-34.45M
EBITDA	562.17M
EBIT	373.38M
Loss Per Share	-0.09

Balance Sheet

The company has 468.42 million in cash and 4.14 billion in debt, giving a net cash position of -3.67 billion.

Cash & Cash Equivalents	468.42M
Total Debt	4.14B
Net Cash	-3.67B
Net Cash Per Share	n/a
Equity (Book Value)	942.32M
Book Value Per Share	2.41
Working Capital	682.43M

Cash Flow

In the last 12 months, operating cash flow was 218.72 million and capital expenditures -66.18 million, giving a free cash flow of 152.54 million.

Operating Cash Flow	218.72M
Capital Expenditures	-66.18M
Free Cash Flow	152.54M
FCF Per Share	n/a

Margins

Gross margin is 54.05%, with operating and profit margins of 5.39% and -0.50%.

Gross Margin	54.05%
Operating Margin	5.39%
Pretax Margin	1.94%
Profit Margin	-0.50%
EBITDA Margin	8.12%
EBIT Margin	5.39%
FCF Margin	2.20%

Dividends & Yields

LON:0R30 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	n/a
Earnings Yield	-1.00%
FCF Yield	4.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R30 has an Altman Z-Score of 1.51 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	7